[Code of Federal Regulations] [Title 40, Volume 14] [Revised as of July 1, 2003] From the U.S. Government Printing Office via GPO Access [CITE: 40CFR79.53] [Page 502-503] TITLE 40--PROTECTION OF ENVIRONMENT CHAPTER I--ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) PART 79--REGISTRATION OF FUELS AND FUEL ADDITIVES--Table of Contents Subpart F--Testing Requirements for Registration Sec. 79.53 Tier 2. (a) Generally. Subject to the provisions of Sec. 79.53(b) through (d), the combustion emissions of each fuel or fuel additive subject to testing under this subpart must be tested in accordance with each of the testing guidelines in Secs. 79.60 through 79.68, except that fuels and additives in the methane and propane fuel families (pursuant to Sec. 79.56(e)(1)(v) and (vi)) need not undergo the Salmonella mutagenicity assay in Sec. 79.68). Similarly, subject to the provisions of Sec. 79.53(b) through (d), the evaporative emissions of each designated evaporative fuel and each designated evaporative fuel additive subject to testing under this subpart must be tested according to each of the testing guidelines in Secs. 79.60 through 79.67 (excluding Sec. 79.68, Salmonella typhimurium Reverse Mutation Assay). (b) Manufacturer Determination. Manufacturers shall determine whether the information gathered pursuant to the literature search in Sec. 79.52(d) contains the results of adequately performed and adequately documented previous testing which provides information reasonably comparable to that supplied by the health tests described in Secs. 79.62 through 79.68 regarding the carcinogenicity, mutagenicity, neurotoxicity, teratogenicity, reproductive/fertility measures, and general toxicity effects of the emissions of the fuel or additive. When manufacturers make an affirmative determination, they need submit only the information gathered pursuant to Sec. 79.52(d) for such tests. EPA maintains final authority in judging whether the information is an adequate substitution in lieu of conducting the associated tests. EPA's determination of the adequacy of existing information shall be guided by the considerations described in paragraph (d) of this section. If EPA finds that the manufacturer has relied upon inadequate test data, then the manufacturer will not be considered to be in compliance until the corresponding tests have been conducted and the results submitted to EPA. (c) Testing. (1) All testing required pursuant to this section must be done in accordance with the procedures, equipment, and facility requirements described in Secs. 79.57, 79.60, and 79.61 regarding emissions generation, good laboratory practices, and inhalation exposure testing, respectively, as well as any other requirements described in this subpart. The laboratory conducting the animal studies shall be registered and in good standing with the United States Department of Agriculture and regularly inspected by United States Department of Agriculture veterinarians. In addition, the facility must be accredited by a generally recognized independent organization which sets laboratory animal care standards. Use of inadequate test protocols or substandard laboratory techniques in performing any testing required by this subpart may result in cancellation of all affected registrations. (2) Carcinogenic or mutagenic effects in animals from emissions exposures shall be determined pursuant to Sec. 79.64 In vivo Micronucleus Assay, Sec. 79.65 In vivo Sister Chromatid Exchange Assay, and Sec. 79.68 Salmonella typhimurium Reverse Mutation Assay. Teratogenic effects and reproductive toxicity shall be examined pursuant to Sec. 79.63 Fertility Assessment/Teratology. General toxicity and pulmonary effects shall be determined pursuant to Sec. 79.62 Subchronic Toxicity Study with Specific Health Effect Assessments. Neurotoxic effects shall be determined pursuant to Sec. 79.66 Neuropathology Assessment and Sec. 79.67 Glial Fibrillary Acidic Protein Assay. (d) EPA Determination. (1) After submission of all information and testing, EPA in its judgment shall determine whether previously conducted tests relied upon in the registration submission are adequately performed and documented and provide information reasonably comparable to that which would be provided by the tests described herein. Manufacturers' submissions shall be sufficiently detailed to allow EPA to judge the adequacy of protocols, techniques, experimental design, statistical analyses, and conclusions. Studies shall be performed using [[Page 503]] generally accepted scientific principles, good laboratory techniques, and the testing guidelines specified in these regulations. (2) EPA shall give appropriate weight when making this determination to the following factors: (i) The age of the data; (ii) The adequacy of documentation of procedures, findings, and conclusions; (iii) The extent to which the testing conforms to generally accepted scientific principles and practices; (iv) The type and number of test subjects; (v) The number and adequacy of exposure concentrations, i.e., emission dilutions; (vi) The degree to which the tested emissions were generated by procedures and under conditions reasonably comparable to those set forth in Sec. 79.57; and (vii) The degree to which the test procedures conform to the testing guidelines set forth in Secs. 79.60 through 79.68 and/or furnish information comparable to that provided by such testing. (3) The test animals shall be rodents, preferably a strain of rat, and testing shall include all of the endpoints covered in Secs. 79.62 through 79.68. All studies shall be properly executed, with appropriate documentation, and in accord with the individual health testing guidelines (Secs. 79.60 through 79.68) of this part, e.g., 90-day, 6- hour per day exposure, minimum. (4) In general, the data in a manufacturer's registration submittal shall be adequate if the duration of a test's exposure period is at least as long, in days and hours, as the inhalation exposure specified in the related health test guideline(s). Data from tests with shorter exposure durations than those specified in the guidelines may be acceptable if the test results are positive (i.e., exhibit adverse effects) and/or include a demonstrable concentration-response relationship. (5) Data in support of a manufacturer's registration submittal shall directly address the effects of inhalation exposure to the whole evaporative and exhaust emissions of the respective fuel or additive or to the whole evaporative and exhaust emissions of other fuels or additives which satisfy the criteria in Sec. 79.56 for classification into the same group as the subject fuel or fuel additive. Data obtained in the testing of a raw liquid fuel or additive/base fuel mixture or a raw, aerosolized fuel or additive/base fuel mixture shall not be adequate to support a manufacturer's registration submittal. Data from testing of evaporative emissions cannot substitute for test data on combustion emissions. Data from testing of combustion emissions cannot substitute for test data on evaporative emissions.